Leteprinim
- Level
- Commodity
- Parent
- 51143000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51143012This classification denotes a neuroprotective agent with the molecular formula C15H13N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NBY3IU407M, chemically known as 4-((3-(1,6-dihydro-6-oxo-9h-purin-9-yl)-1-oxopropyl)amino)benzoic acid but generally known as leteprinim, which bears US NIH Compound Identifier 132123. European Medicines Agency schedules Leteprinim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02897MIG. The term LETEPRINIM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). Most nations schedule leteprinim under HS 29335995 and SITC 51576. As of Q4 2014, LETEPRINIM remains the US FDA Preferred Term for this commodity. Leteprinim bears US NLM identifiers UMLS ID C0252664 and NCI Concept Code C80995. SMILES: O=C(NC1CCC(CC1)C(=O)O)CCN1C2[NH]CNC(=O)C2NC1.
Same parent
Under 51143000 · 22Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.